Congratulations to the 2019 Award Winners
Nominate or apply for an award at US HUPO 2020. Deadline is October 31, 2019. Scroll down for details on how to nominate or apply for these four awards.
Jennifer Van Eyk
Max Planck Institute
Harvard Medical School
Catherine E. Costello
School of Medicine
Donald F. Hunt
to Proteomics Award
Gilbert S. Omenn
Robert J. Cotter
New Investigator Award
in Proteomics Award
Best Poster Awards 2019
Graduate Student: Yekaterina Kori (University of Pennsylvania) and Postdoc: Andy Qi (NCI, NIH) were selected as "Best Poster" winners. Each was awarded $300. Congratulations!
Best Tweets at US HUPO 2019
Angela Kruse (Cornell University) and Erica Pratt (University of Minnesota) are recognized for their quality tweets on US HUPO 2019. Each receives a $50 award. Honorable mention tweeters are Paolo Cifani (NYU), Alexey Nesvizhskii (University of Michigan), and John Yates (The Scripps Research Institute).
Award Nominations for 2020 - Deadline is October 31, 2019
Application or Nomination Details for each award below.
Donald F. Hunt Distinguished Achievement in Proteomics Award
The Donald F. Hunt Distinguished Achievement in Proteomics award recognizes a focused or singular achievement in the field of proteomics. Eligibility is restricted to members of US HUPO. Nominations will be held for three years.This award is fully supported by the Journal of Proteome Research (JPR) and was established to recognize Prof. Hunt's significant contributions to the field of proteomics. Prof. Hunt was honored as the first recipient of this award which now bears his name. The award recipient will be honored at the US HUPO annual conference with a commemorative plaque, cash award of $2,500, and will present a plenary lecture on Monday morning at the meeting (40-min talk).
This award is fully funded by
Jennifer Van Eyk, 2019 Recipient
Dr. Van Eyk has a longstanding record of excellence in applying cutting-edge analytical technologies to address clinically relevant biological hypotheses and in translation into clinical therapies or diagnostics. Dr. Van Eyk is a Professor of Medicine at Cedars-Sinai Medical Center. In keeping with her research mission of bringing discovery to patient care, Dr. Van Eyk serves as Director of the Basic Science Research in the Barbra Streisand Woman’s Heart Center, Director of the Advanced Clinical Biosystems Research Institute, and most recently co-director of the Cedars-Sinai Precision Health focused on in-hospital and population individualization of health care.
Dr. Van Eyk is an international leader in the area of clinical proteomics and her lab remains focused on developing technical pipelines for de novo discovery and larger scale quantitative mass spectrometry methods. These encompass data dependent acquisition- and data independent acquisition-mass spectrometry methods for discovery, as well as targeted multiple reaction monitoring (MRM, also known as SRM). Her laboratory is recognized for the rigor it applies to technical quality, control, and reproducibility of increasingly complex datasets that can address key clinical questions with improvements in throughput to enable continuous assessments of large healthy cohorts and clinical grade assays focusing on brain and cardiovascular diseases. Her list of achievements includes more than 325 published articles, over a 20 patents, and numerous research and leadership awards.
Lifetime Achievement in Proteomics Award
The Lifetime Achievement in Proteomics Award recognizes a career of discovery that has made a lasting impact on the field of proteomics.
Catherine E. Costello, 2019 Recipient
Prof. Costello’s research has revolutionized glycomics by enabling comprehensive structural characterization of free glycans and glycoconjugates in a sensitive and high throughput fashion. In the 1980s she was among the first to recognize the potential of combining emerging soft ionization techniques with tandem mass spectrometry for characterization of glycans. Today, her 1988 publication defining the dissociation nomenclature for glycans remains highly cited. Prof. Costello delineated the strategy of producing the greatest degree of structural detail on glycans in a single tandem mass spectrometry step. She recognized that while collisional dissociation provides useful information, its utility is limited by low abundances of key cross-ring cleavage product ions. She developed activated electron dissociation methods for glycans and glycoconjugates that are inherently more effective for producing cross-ring cleavages. This has included studies of dissociation mechanisms and influences of metal cationization. Prof. Costello and her co-workers also pioneered Fourier Transform mass spectrometry of glycans and glycoconjugates with the application of electron-based activation/dissociation methods and demonstrated these methods on a time scale compatible with on-line LC-FTICR MS/MS and LC-IM-QTOF MS/MS. Prof. Costello was the first to demonstrate top-down tandem MS analysis of intact glycoproteins. This is significant because most cell surface and secreted proteins are glycosylated and progress in biomedicine depends on the ability to characterize glycosylated proteoforms.
Prof. Costello’s research activities define the present state of the art in glycan and glycoconjugate tandem mass spectrometry. These achievements address the needs in biomedicine for high throughput sequencing of glycans and glycoconjugates and for top-down analysis of intact glycoproteins. She has also explored the effects of sequence variants and post-translational modifications on the misfolding of proteins that underlie neurodegenerative and systemic amyloid diseases, the evolution of cardiovascular disease, and MHC-presentation of antigenic peptides during infection and autoimmunity.
Dr. Catherine E. Costello is a William Fairfield Warren Distinguished Professor, Departments of Biochemistry, Physiology & Biophysics, and Chemistry, Boston University, Boston, MA. She has served as President of ASMS, HUPO and the International Mass Spectrometry Foundation.
Gilbert S. Omenn Computational Proteomics Award
This award recognizes the essential nature of computational methodology and software in proteomics. Specifically, this award acknowledges the specific achievements of scientists that have developed bioinformatics, computational, statistical methods and/or software used by the proteomics community, broadly defined. The award is named in honor of Gil Omenn, a US HUPO Past President, leader of the Human Proteome Project, and influential proteomics researcher. The award recipient will be honored at the US HUPO annual conference with a commemorative plaque and cash award of $2,500, and will present an award lecture.
Juergen Cox - 2019 Recipient
Dr. Cox earned his Master’s degree in physics from RWTH Aachen University in Germany and received his PhD from the Massachusetts Institute of Technology in theoretical particle physics. He then worked at the Basel-based bioinformatics company GeneData and, after a postdoc at the Technical University of Munich, went on to work at the Max Planck Institute of Biochemistry in Munich on problems in computational proteomics. There he heads since 2014 the research lab for computational systems biochemistry. Dr. Cox has contributed greatly to the toolset of computational proteomics by developing the software platforms MaxQuant and Perseus which are in frequent use in the proteomics community. Dr. Cox has co-authored 126 peer-reviewed journal articles.
Past Recipients of the Computational Proteomics Award
- 2018: Hannes Roest (University of Toronto)
- 2017: Alexey Nesvizhskii (University of Michigan)
- 2016: Brendan MacLean (University of Washington)
Robert J. Cotter New Investigator Award
This award was established to honor the memory of Bob Cotter, a founding member of US HUPO, for his many contributions to scientific research and for his legacy as a mentor to young scientists. Each year, the award will be given to an individual early in his or her career, in recognition of significant achievements in proteomics, broadly defined. The award recipient will be honored at the US HUPO annual conference with a commemorative plaque, $2,500 cash award, and will present an award lecture.
Wilhelm Haas - 2019 Recipient
Dr. Haas is an Assistant Professor of Medicine at the Massachusetts General Hospital (MGH) Cancer Center and Harvard Medical School in Boston. He started his laboratory in 2013 and his research group focuses on advancing technologies in mass spectrometry-based proteomics and their application in disease-related basic and clinical research. Born in Austria he did his undergraduate and graduate work at the University of Graz, Austria. He then worked as a postdoctoral fellow in the laboratory of Dr. Steven Gygi at Harvard Medical School, where, among other things, he worked on new technologies enabling multiplexed quantitative proteomics. His lab at the MGH Cancer Center is using quantitative proteomics for global mapping of the dynamics of interactomes to study various questions in cancer research, including the search of biomarkers and novel drug targets to improve personalized therapies for cancer.
Past Recipients of the New Investigator Award
- 2018: Leslie Hicks (University of North Carolina, Chapel Hill)
- 2017: Peter Nemes (George Washington University) and Christine Vogel (New York University)
- 2016: Paola Picotti (ETH Zurich)
- 2015: Bernd Bodenmiller (University of Zurich)
- 2014 Judith Villen (University of Washington)
- 2013 Rebecca Gundry (Medical College of Wisconsin)